The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doshi Dipal since 2015.
This trader's CIK number is 1613084.
At the time of last reporting, Doshi Dipal was the CEO of Entrada Therapeutics, Inc.. (stock ticker symbol TRDA).
Also see all insider trading activities at Entrada Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | TRDA | 0 | $0 | 6,900 | $111,190 | 0 | $0 |
| 2023 | TRDA | 0 | $0 | 15,092 | $220,139 | 0 | $0 |
| 2022 | TRDA | 0 | $0 | 46,012 | $776,027 | 10,000 | $17,400 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | FOLD | 0 | $0 | 6,250 | $86,687 | 12,500 | $0 |
1. Entrada Therapeutics, Inc. (TRDA)
2. Amicus Therapeutics, Inc. (FOLD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-12 | TRDA | Sale | 300 | 18.00 | 5,400 |
| 2024-07-15 | TRDA | Sale | 1,600 | 17.81 | 28,497 |
| 2024-06-13 | TRDA | Sale | 1,000 | 16.17 | 16,174 |
| 2024-05-16 | TRDA | Sale | 1,800 | 15.00 | 27,000 |
| 2024-05-17 | TRDA | Sale | 1,200 | 15.11 | 18,129 |
| 2024-01-16 | TRDA | Sale | 1,000 | 15.99 | 15,990 |
| 2023-12-20 | TRDA | Sale | 1,000 | 15.00 | 15,000 |
| 2023-11-13 | TRDA | Sale | 1,000 | 16.23 | 16,230 |
| 2023-10-17 | TRDA | Sale | 1,000 | 15.00 | 15,000 |
| 2023-09-13 | TRDA | Sale | 1,000 | 15.00 | 15,000 |
| 2023-08-14 | TRDA | Sale | 1,000 | 15.67 | 15,671 |
| 2023-04-27 | TRDA | Sale | 2,000 | 13.71 | 27,422 |
| 2023-04-17 | TRDA | Sale | 2,092 | 18.01 | 37,674 |
| 2023-03-27 | TRDA | Sale | 2,000 | 15.07 | 30,140 |
| 2023-02-28 | TRDA | Sale | 2,000 | 12.00 | 24,000 |
| 2023-01-27 | TRDA | Sale | 2,000 | 12.00 | 24,002 |
| 2022-11-28 | TRDA | Sale | 2,000 | 13.91 | 27,826 |
| 2022-10-25 | TRDA | Sale | 12,061 | 20.76 | 250,338 |
| 2022-10-27 | TRDA | Sale | 2,000 | 21.66 | 43,326 |
| 2022-10-20 | TRDA | Sale | 811 | 18.01 | 14,606 |
| 2022-10-21 | TRDA | Sale | 2,786 | 18.28 | 50,916 |
| 2022-10-24 | TRDA | Sale | 2,342 | 19.27 | 45,137 |
| 2022-09-26 | TRDA | Sale | 3,083 | 15.76 | 48,588 |
| 2022-09-27 | TRDA | Sale | 4,419 | 15.43 | 68,194 |
| 2022-09-28 | TRDA | Sale | 3,085 | 15.23 | 46,996 |
| 2022-09-21 | TRDA | Sale | 3,402 | 15.12 | 51,424 |
| 2022-09-23 | TRDA | Sale | 1,023 | 15.07 | 15,412 |
| 2022-09-15 | TRDA | Sale | 200 | 15.04 | 3,008 |
| 2022-09-15 | TRDA | Sale | 200 | 15.04 | 3,008 |
| 2022-09-15 | TRDA | Sale | 200 | 15.04 | 3,008 |
| 2022-09-15 | TRDA | Sale | 200 | 15.04 | 3,008 |
| 2022-09-15 | TRDA | Sale | 200 | 15.04 | 3,008 |
| 2022-08-29 | TRDA | Sale | 1,639 | 13.36 | 21,892 |
| 2022-08-30 | TRDA | Sale | 190 | 12.00 | 2,280 |
| 2022-08-31 | TRDA | Sale | 171 | 12.00 | 2,052 |
| 2022-07-27 | TRDA | Sale | 2,000 | 12.00 | 24,000 |
| 2022-06-27 | TRDA | Sale | 4,000 | 12.00 | 48,000 |
| 2022-01-13 | TRDA | Option Ex | 10,000 | 1.74 | 17,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-07-07 | FOLD | Option Ex | 12,500 | .00 | 0 |
| 2015-07-08 | FOLD | Sale | 6,250 | 13.87 | 86,687 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doshi Dipal (CEO of Entrada Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.